/
Other
Pediatric Patients
11
Pipeline Programs↗
18
Active Trials↗
39
Companies Involved↗
Pediatric Patients is an emerging landscape with 11 programs across 39 companies. The most active players are Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical4
Phase 1
No programs
Phase 35
Approved
No programs
Analysis
Trial Status
175
clinical trials
Completed106 · 61%
Terminated25 · 14%
Unknown status19 · 11%
Recruiting9 · 5%
Withdrawn5 · 3%
Not yet recruiting4 · 2%
Other7 · 4%
Clinical Trials
Trial Activity
175 trials
A Crossover Clinical Study to Evaluate the Effect of Chitosan Mouthwash on Recurrence of Black Stains in Pediatric Patients
Recruiting·—·N/A·NCT06714695·17 enrolled
Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis
Recruiting·—·Phase 4·NCT06151392·140 enrolled
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
Recruiting·—·N/A·NCT06326983·58 enrolled
Effect of Intraperitoneal Bupivacaine with Dexmedotomidine or Fentanyl for Post-Operative Analgesia Following Laparoscopy in Pediatric Patients
Not yet recruiting·—·N/A·NCT06694207·80 enrolled
Page 1 of 12
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)